abnormal vitreous body morphology_Nos2<tm1Mrl>/Nos2<tm1Mrl>

http://metadb.riken.jp/0002699I129S7SvEvBrdNos2tm1MrlNos2tm1MrlNos2tm1Mrl

abnormal vitreous body morphology_Nos2<tm1Mrl>/Nos2<tm1Mrl>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• nitric oxide synthase 2, inducible
  http://metadb.riken.jp/db/mgi_rdf/MGI:97361

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Nos2<tm1Mrl>/Nos2<tm1Mrl>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Nos2<tm1Mrl>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal vitreous body morphology
  http://purl.obolibrary.org/obo/MP_0002699

文献

http://purl.org/net/cito/citesAsAuthority

• F. Sennlaub, et.al., Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy., The Journal of clinical investigation, 2001, 107
  http://rdf.ncbi.nlm.nih.gov/pubmed/11254671